| Name | Title | Contact Details |
|---|
United Cerebrial Palsy is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
US Script, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Fresno, CA. To find more information about US Script, Inc., please visit www.usscript.com
Partners Med B is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
e4e is an IT-enabled Services and Business Process Outsourcing company that has deep domain and contextual expertise in the US Healthcare Business Services ecosystem, with an enviable client list of reputed companies. e4e was founded in 2000 and has over 2,500 employees globally, with offices in the U.S., India, and the Philippines. With over 150 years of cumulative senior management experience, we have the capability of delivering compelling business value to our clients, right shoring between our geographical sites and our best practices.